Protein phosphatase 1 regulatory subunit 3A is an enzyme that in humans is encoded by the PPP1R3Agene.[1][2]
The glycogen-associated form of protein phosphatase-1 (PP1) derived from skeletal muscle is a heterodimer composed of a 37-kD catalytic subunit (MIM 176875) and a 124-kD targeting and regulatory subunit, referred to as PP1G by Hansen et al. (1995). PP1G binds to muscle glycogen with high affinity, thereby enhancing dephosphorylation of glycogen-bound substrates for PP1 such as glycogen synthase (e.g., MIM 138570) and glycogen phosphorylase kinase (e.g., MIM 306000). Phosphorylation at ser46 of the PP1G subunit in response to insulin increases PP1 activity, while phosphorylation at ser65 in response to adrenaline causes dissociation of the catalytic subunit from the G subunit and inhibits glycogen synthesis. Because of these functions, PP1G was postulated to be involved in noninsulin-dependent diabetes mellitus (NIDDM; MIM 125853) and obesity.[supplied by OMIM][2]
References
↑Chen YH, Hansen L, Chen MX, Bjorbaek C, Vestergaard H, Hansen T, Cohen PT, Pedersen O (Nov 1994). "Sequence of the human glycogen-associated regulatory subunit of type 1 protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with NIDDM". Diabetes. 43 (10): 1234–41. doi:10.2337/diabetes.43.10.1234. PMID7926294.
Hubbard MJ, Cohen P (1990). "Regulation of protein phosphatase-1G from rabbit skeletal muscle. 1. Phosphorylation by cAMP-dependent protein kinase at site 2 releases catalytic subunit from the glycogen-bound holoenzyme". Eur. J. Biochem. 186 (3): 701–9. doi:10.1111/j.1432-1033.1989.tb15263.x. PMID2558013.
Hansen L, Hansen T, Vestergaard H, et al. (1995). "A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin". Hum. Mol. Genet. 4 (8): 1313–20. doi:10.1093/hmg/4.8.1313. PMID7581368.
Berrebi-Bertrand I, Souchet M, Camelin JC, et al. (1998). "Biophysical interaction between phospholamban and protein phosphatase 1 regulatory subunit GM". FEBS Lett. 439 (3): 224–30. doi:10.1016/S0014-5793(98)01364-7. PMID9845327.
Walker KS, Watt PW, Cohen P (2000). "Phosphorylation of the skeletal muscle glycogen-targeting subunit of protein phosphatase 1 in response to adrenaline in vivo". FEBS Lett. 466 (1): 121–4. doi:10.1016/S0014-5793(99)01771-8. PMID10648825.
Wang G, Qian R, Li Q, et al. (2002). "The association between PPP1R3 gene polymorphisms and type 2 diabetes mellitus". Chin. Med. J. 114 (12): 1258–62. PMID11793847.
Savage DB, Agostini M, Barroso I, et al. (2002). "Digenic inheritance of severe insulin resistance in a human pedigree". Nat. Genet. 31 (4): 379–84. doi:10.1038/ng926. PMID12118251.
Hillier LW, Fulton RS, Fulton LA, et al. (2003). "The DNA sequence of human chromosome 7". Nature. 424 (6945): 157–64. doi:10.1038/nature01782. PMID12853948.
Lerín C, Montell E, Nolasco T, et al. (2003). "Regulation and function of the muscle glycogen-targeting subunit of protein phosphatase 1 (GM) in human muscle cells depends on the COOH-terminal region and glycogen content". Diabetes. 52 (9): 2221–6. doi:10.2337/diabetes.52.9.2221. PMID12941760.
Alcoser SY, Hara M, Bell GI, Ehrmann DA (2004). "Association of the (AU)AT-rich element polymorphism in PPP1R3 with hormonal and metabolic features of polycystic ovary syndrome". J. Clin. Endocrinol. Metab. 89 (6): 2973–6. doi:10.1210/jc.2003-031189. PMID15181086.
Hayashida Y, Goi T, Hirono Y, et al. (2005). "PPP1R3 gene (protein phosphatase 1) alterations in colorectal cancer and its relationship to metastasis". Oncol. Rep. 13 (6): 1223–7. doi:10.3892/or.13.6.1223. PMID15870946.
Olsen JV, Blagoev B, Gnad F, et al. (2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks". Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID17081983.
